Results 91 to 100 of about 3,891 (306)

A Zeroripple High Voltage Gain Convertor with Coupledinductors

open access: yesJournal of Harbin University of Science and Technology, 2019
In this paper, a high voltage gain DC-DC converter with coupled inductor and ripple free is proposed for low voltage renewable energy generation system,such as photovoltaic, fuel cell and so on.The coupling inductor technology is introduced on the basis ...
LIANG Wen juan   +3 more
doaj   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau   +8 more
wiley   +1 more source

Soft‐Switching Non‐Isolated High Step‐Up DC‐DC Converter With Continuous Input Current for PV Application

open access: yesIET Power Electronics
In this paper, a high step‐up DC‐DC boost converter is introduced, which utilises the coupled inductor and switched capacitor techniques to increase voltage gain, adjustable by changing the turn ratio of the coupled inductors.
Sadegh Heidari Beni   +4 more
doaj   +1 more source

A zero voltage transition interleaved DC-DC converter with reduced voltage stress

open access: yesMajlesi Journal of Electrical Engineering
This paper presents an interleaved converter designed to achieve a high voltage gain using a combination of coupled inductors and switched capacitors.
Hosein Talgini   +2 more
doaj   +1 more source

Passivity Criterions of Networks With General Fractional Order Coupled Inductors

open access: yesIEEE Access, 2019
Fractional order coupled inductor (FCI) was proposed recently which can enrich existing circuit element system. In this paper, the passivity conditions of FCI are discussed.
Guishu Liang   +3 more
doaj   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

A Current-Doubler Rectifier with Coupled Inductors for High Step-Down Applications

open access: yes, 2014
[[abstract]]In this paper, a current-doubler rectifier with coupled inductors for high step-down applications is proposed. The proposed current-doubler rectifier includes two sets of coupled inductors, which can extend duty ratio to reduce the pea ...
T.-F. Wu;C.-T. Tsai;C.-L. Shen;Y.-M. Chen
core   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

open access: yesMolecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu   +10 more
wiley   +1 more source

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

open access: yesMolecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy